Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

PURPOSE: We previously reported that constitutive STAT3 activation is a prominent feature of the activated B-cell subtype of diffuse large B-cell lymphomas (ABC-DLBCL). In this study, we investigated whether STAT3 activation can risk stratify patients with DLBCL. PATIENTS AND METHODS: By an immunohi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huang, Xin, Meng, Bin, Iqbal, Javeed, Ding, B. Belinda, Perry, Anamarija M., Cao, Wenfeng, Smith, Lynette M., Bi, Chengfeng, Jiang, Chunsun, Greiner, Timothy C., Weisenburger, Dennis D., Rimsza, Lisa, Rosenwald, Andreas, Ott, German, Delabie, Jan, Campo, Elias, Braziel, Rita M., Gascoyne, Randy D., Cook, James R., Tubbs, Raymond R., Jaffe, Elaine S., Armitage, James O., Vose, Julie M., Staudt, Louis M., McKeithan, Timothy W., Chan, Wing C., Ye, B. Hilda, Fu, Kai
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2013
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871513/
https://ncbi.nlm.nih.gov/pubmed/24220563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.45.6004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares